MX337348B - Metodos para purificar virus utilizando cromatografia de permeacion en gel. - Google Patents
Metodos para purificar virus utilizando cromatografia de permeacion en gel.Info
- Publication number
- MX337348B MX337348B MX2013012627A MX2013012627A MX337348B MX 337348 B MX337348 B MX 337348B MX 2013012627 A MX2013012627 A MX 2013012627A MX 2013012627 A MX2013012627 A MX 2013012627A MX 337348 B MX337348 B MX 337348B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- gel permeation
- permeation chromatography
- purifying viruses
- viruses
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicinal Preparation (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161480561P | 2011-04-29 | 2011-04-29 | |
| PCT/CA2012/000406 WO2012145837A1 (en) | 2011-04-29 | 2012-04-27 | Methods of purifying viruses using gel permeation chromatography |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013012627A MX2013012627A (es) | 2014-05-13 |
| MX337348B true MX337348B (es) | 2016-02-29 |
Family
ID=47067091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013012627A MX337348B (es) | 2011-04-29 | 2012-04-27 | Metodos para purificar virus utilizando cromatografia de permeacion en gel. |
Country Status (15)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2819236A1 (en) | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| MX373096B (es) * | 2010-12-02 | 2020-04-27 | Oncolytics Biotech Inc | Formulaciones virales líquidas. |
| RS57864B1 (sr) * | 2013-06-17 | 2018-12-31 | De Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Spo | Postupci za sprečavanje agregacije virusnih komponenti |
| CA3104392A1 (en) | 2018-07-04 | 2020-01-09 | Probiogen Ag | Method for purifying an enveloped virus |
| CN111812313B (zh) * | 2020-06-22 | 2021-10-08 | 北京生物制品研究所有限责任公司 | 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法 |
| CN114544815B (zh) * | 2022-03-01 | 2023-10-27 | 中牧实业股份有限公司 | 一种山羊痘病毒的定量检测方法 |
| CN116718524B (zh) * | 2023-06-26 | 2025-11-07 | 西安交通大学 | 一种基于细胞膜色谱技术的病毒颗粒检测方法 |
| HUP2400154A1 (hu) * | 2024-02-29 | 2025-09-28 | Pecsi Tudomanyegyetem | Elúciós oldat és tisztítási eljárás |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| DE69029765T2 (de) * | 1989-07-24 | 1997-05-15 | Bayer Ag | Stabilisierung von hochgereinigten Proteinen |
| ES2264126T3 (es) * | 1994-05-16 | 2006-12-16 | MERCK & CO., INC. | Vacunas contra el papilomavirus. |
| KR100918187B1 (ko) * | 1998-02-17 | 2009-09-22 | 쉐링 코포레이션 | 바이러스를 포함하는 조성물 및 바이러스 제제의 농축방법 |
| IL157304A0 (en) | 2001-03-16 | 2004-02-19 | Oncolytics Biotech Inc | Method of extracting virus from cell culture |
| DE60327069D1 (de) * | 2002-04-30 | 2009-05-20 | Oncolytics Biotech Inc | Verbesserte reinigungsmethode für viren |
| US7901921B2 (en) * | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
| EP1878791A1 (en) * | 2006-07-11 | 2008-01-16 | Bia Separations D.O.O. | Method for influenza virus purification |
| CA2662569C (en) * | 2006-08-07 | 2017-01-03 | Japan As Represented By Director General Of National Institute Of Infectious Diseases | Process for preparing live smallpox vaccine |
| SG191602A1 (en) * | 2007-03-12 | 2013-07-31 | Oncolytics Biotech Inc | Reoviruses having modified sequences |
| AU2008321016B2 (en) * | 2007-11-12 | 2013-03-28 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| US8227577B2 (en) * | 2007-12-21 | 2012-07-24 | Hoffman-La Roche Inc. | Bivalent, bispecific antibodies |
| CA2819236A1 (en) * | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| MX373096B (es) * | 2010-12-02 | 2020-04-27 | Oncolytics Biotech Inc | Formulaciones virales líquidas. |
-
2012
- 2012-04-27 EA EA201391605A patent/EA201391605A1/ru unknown
- 2012-04-27 CA CA2832367A patent/CA2832367A1/en not_active Abandoned
- 2012-04-27 MX MX2013012627A patent/MX337348B/es active IP Right Grant
- 2012-04-27 DK DK12776970.1T patent/DK2702147T3/da active
- 2012-04-27 WO PCT/CA2012/000406 patent/WO2012145837A1/en not_active Ceased
- 2012-04-27 ES ES12776970T patent/ES2822199T3/es active Active
- 2012-04-27 EP EP12776970.1A patent/EP2702147B1/en active Active
- 2012-04-27 KR KR1020137031292A patent/KR20140024406A/ko not_active Ceased
- 2012-04-27 AU AU2012248082A patent/AU2012248082B2/en active Active
- 2012-04-27 TW TW101115116A patent/TW201307561A/zh unknown
- 2012-04-27 SG SG2013075569A patent/SG194449A1/en unknown
- 2012-04-27 KR KR1020197006419A patent/KR102151890B1/ko active Active
- 2012-04-27 CN CN201280020376.8A patent/CN103492557B/zh active Active
- 2012-04-27 JP JP2014506699A patent/JP6029651B2/ja active Active
- 2012-04-27 US US13/457,642 patent/US20120273424A1/en not_active Abandoned
-
2013
- 2013-09-17 IL IL228491A patent/IL228491A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190026059A (ko) | 2019-03-12 |
| AU2012248082A1 (en) | 2013-05-09 |
| EP2702147A1 (en) | 2014-03-05 |
| CA2832367A1 (en) | 2012-11-01 |
| EA201391605A1 (ru) | 2014-02-28 |
| CN103492557B (zh) | 2015-07-29 |
| IL228491A0 (en) | 2013-12-31 |
| SG194449A1 (en) | 2013-12-30 |
| WO2012145837A1 (en) | 2012-11-01 |
| CN103492557A (zh) | 2014-01-01 |
| DK2702147T3 (da) | 2020-09-28 |
| IL228491A (en) | 2017-05-29 |
| JP2014516515A (ja) | 2014-07-17 |
| ES2822199T3 (es) | 2021-04-29 |
| MX2013012627A (es) | 2014-05-13 |
| AU2012248082B2 (en) | 2015-08-20 |
| KR102151890B1 (ko) | 2020-09-03 |
| TW201307561A (zh) | 2013-02-16 |
| KR20140024406A (ko) | 2014-02-28 |
| US20120273424A1 (en) | 2012-11-01 |
| EP2702147B1 (en) | 2020-07-15 |
| EP2702147A4 (en) | 2014-11-05 |
| JP6029651B2 (ja) | 2016-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG194449A1 (en) | Methods of purifying viruses using gel permeation chromatography | |
| MX392274B (es) | Cartuchos utiles en limpieza de soluciones de dialisis. | |
| WO2013078170A8 (en) | Purification of anti-c-met antibodies | |
| MX2015011199A (es) | Agentes terapéuticos de csf1. | |
| MX2015007888A (es) | Compuestos antivirales. | |
| PH12013501683A1 (en) | Yeast-based therapeutic for chronic hepatitis b infection | |
| ECSP13013060A (es) | Composiciones de nucleasa terapéuticas y métodos | |
| MX378747B (es) | Complejos de proteínas de citomegalovirus. | |
| MX2010004892A (es) | Terapia de combinacion para tratar infecciones virales persistentes. | |
| WO2011160024A3 (en) | Compounds useful as antiviral agents, compositions, and methods of use | |
| PH12014502628B1 (en) | Compositions and methods related to the prevention and treatment of rabies infection | |
| MX360245B (es) | Composiciones que comprenden inmunoglobulinas de tipo secretor. | |
| SI3660032T1 (sl) | Postopki zajemanja in čiščenja beljakovin, izraženih v nesesalskem sistemu | |
| BR112016022214A2 (pt) | rnase para uso no tratamento ou prevenção de infecções virais | |
| WO2013028334A3 (en) | Use of small molecules in methods for purification of biomolecules | |
| MX2019006568A (es) | Eliminacion de ligandos lixiviados de purificacion de afinidad. | |
| TN2013000388A1 (en) | Anticoagulant antidotes | |
| MX2018003080A (es) | Cartuchos utiles en soluciones de dialisis de limpieza. | |
| EA201590778A1 (ru) | ОЧИСТКА КОМБИНИРОВАННОЙ ГАЛАКТОЦЕРЕБРОЗИД-β-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC) | |
| WO2014160098A3 (en) | Bordetella specific human recombinant antibodies and uses thereof | |
| WO2012164003A3 (de) | Solareinrichtung mit reflektorvorrichtung und reflektorvorrichtung | |
| PH12014501285A1 (en) | Liquid activation system | |
| WO2015022470A3 (fr) | Vaccins contre la maladie de lyme | |
| ITAN20120093A1 (it) | Dispositivo per la decantazione del vino. | |
| MY171384A (en) | Composition and methods related to the prevention and treatment of rabies infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |